Company / Current Liabilities per Share
Protagonist Therapeutics, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.71
FY2025
5-year range
$0.37 / $0.95
FY2021-FY2025
Trend
-1.9%
vs FY2024
Sector context
#130 of 210
Health Care
What the data says
At $0.71, Protagonist Therapeutics, Inc.'s current liabilities per share ranks #81 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.37 in FY2023 to $2.40 in FY2017.
Based on SEC 10-K filings.
0.71 in FY2025 with a 5-year CAGR of -9.4%.
Increased from $0.37 to $0.71 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +4.0%
- 5-Year CAGR
- -9.4%
- 10-Year CAGR
- -
Sector benchmark
-97.0% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 1.9% year-over-year.
- Ranks #130 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2017.
- Lowest current liabilities per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.71 | -1.9% |
| FY2024 | $0.73 | +94.3% |
| FY2023 | $0.37 | -41.0% |
| FY2022 | $0.64 | -33.1% |
| FY2021 | $0.95 | -18.8% |
| FY2020 | $1.17 | -14.4% |
| FY2019 | $1.37 | +16.9% |
| FY2018 | $1.17 | -51.4% |
| FY2017 | $2.40 | +143.0% |
| FY2016 | $0.99 | -92.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026